Robotic rehabilitation technologies for the treatment of neurological disorders.
Medical foods and prescription drugs for chronic kidney disease, depression, and chronic pain.
Fully synthetic electrospun implantable scaffolds for regenerative medical applications.
Leader in men's health R&D, developed the first convenient and long-acting formulation of hCG.
Developing a point-of-care ultrasound-based device for early identification of postoperative blood clots.
Online learning platform for medical students that analyzes coursework and provides customized learning materials.
Utilizing advanced materials to develop injury prevention technologies (originating from Robert Langer's MIT lab).
Needle guidance system combining high-resolution ultrasound imaging technology and interventional access.
Developing transdermal patch reformulations of drugs used to treat of chemotherapy-induced nausea and vomiting (CINV).
Immediate and permanent BPH symptom relief through an easy procedure performed in an outpatient setting.
Novel engineered insulin platform technology for the treatment of T1D, T2D and cancer.
Using behavioral economics to drastically improve care plan adherence in patients with chronic conditions.
Sign up for our briefings to stay up to date with the latest in healthcare and life science venture capital.
We also offer career and consulting opportunities at our portfolio companies and external partners.
Great! We will keep you up to date with the latest.Tell us a little more and we will reach out to you personally.
We will get back to you soon.